Document is current

Any future updates will be listed below

Class III Antiarrhythmic Drug Cavutilide Does Not Increase the Susceptibility of the Ventricles to Phenylephrine-Induced Tachyarrhythmias Due to the Direct Dependence of the Effect on the Frequency of Myocardial Activation

Crossref DOI link: https://doi.org/10.1007/s10517-025-06479-8

Published Online: 2025-09-25

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark